Melanoma Marker Antibody (NKI/beteb) is a mouse monoclonal IgG2b antibody that detects Melanoma Marker in human samples through immunofluorescence (IF) and immunohistochemistry with paraffin-embedded sections (IHCP). Melanoma Marker is crucial for identifying malignant melanoma, a serious form of skin cancer that arises from melanocytes, the pigment-producing cells responsible for melanin synthesis. Understanding Melanoma Marker′s structure is vital, as Melanoma Marker plays a significant role in regulating cell proliferation and apoptosis, processes often dysregulated in cancer. Melanoma Marker′s structure includes specific domains that facilitate interaction with other cellular components, influencing signaling pathways that can lead to tumorigenesis. Anti-Melanoma Marker antibody (NKI/beteb) enables researchers to gain insights into melanoma development and progression, ultimately contributing to the advancement of targeted therapies and improved diagnostic strategies for this aggressive cancer type.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Melanoma Marker Antibody (NKI/beteb) | sc-52704 | 200 µg/ml | $322.00 | |||
Melanoma Marker Antibody (NKI/beteb): m-IgG Fc BP-HRP Bundle | sc-536862 | 200 µg Ab; 10 µg BP | $361.00 | |||
Melanoma Marker Antibody (NKI/beteb): m-IgGκ BP-HRP Bundle | sc-534029 | 200 µg Ab; 40 µg BP | $361.00 | |||
Melanoma Marker Antibody (NKI/beteb): m-IgG2b BP-HRP Bundle | sc-549838 | 200 µg Ab; 10 µg BP | $361.00 |